Neuroactive drugs show promising anti-glioblastoma effects in preclinical trials 💊🧠🧪 www.news-medical.net/news/2024092...#glioblastoma#cancer#drugrepurposing#neuroactive#vortioxetine#braincancer#preclinical#oncology#healthinnovation#drugdiscovery
Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the treatment of glioblastoma. Vortioxetine, an antidepressant, showed promising anti-g...
Apple Watch Series 10: All You Need to Know About Intelligent Smartwatch See here - techchilli.com/artificial-i...#AppleWatchSeries10#AppleGlowtime#Smartwatch#WearableTech#AI#FitnessTech#HealthInnovation#AppleEvent#TechNews
We're so proud of the teams behind our PRINCIPLE and PANORAMIC trials who were honoured with the prestigious #PrixGalien#HealthInnovation#NDPCHSReview24www.phc.ox.ac.uk/news/princip...
The teams behind the PRINCIPLE and PANORAMIC clinical trials, run in the Clinical Trials Unit at the Nuffield Department of Primary Care Health Sciences, have been awarded the prestigious Prix Galien ...
The QR4 tool could revolutionize heart disease prevention🫀 It spots high-risk patients current tools miss - like COPD, learning disabilities, and even postnatal depression. With a better picture of a patient's risk, doctors can help save lives 💪 #HealthInnovation#NDPCHSReview24bit.ly/4edbucS
Collaborative research, led from NDPCHS and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular disease...
Understanding prescribing trends helps the NHS make #opioid#HealthInnovation#NDPCHSReview24bit.ly/3My2XFN
Amid concerns that the COVID-19 pandemic might have led to increases in opioid prescribing, a new study from researchers at the Bennett Institute for Applied Data Science, University of Oxford, demons...
Cutting back on #bloodpressurebit.ly/3LIu1ll#Deprescribing#HealthInnovation#NDPCHSReview24
In the largest study of its kind to date, new research from the Nuffield Department of Primary Care Health Sciences, University of Oxford has found that reducing blood pressure medication in older adu...
In the largest-ever study on cancer symptoms in children and young adults our researchers uncovered 29 key symptoms - some never linked to cancer before. Early diagnosis is tricky, but these findings could help save lives. #CancerResearch#HealthInnovation#NDPCHSReview24bit.ly/3APbdP9
Researchers from the Nuffield Department of Primary Care Health Sciences have conducted the largest ever study examining symptoms of cancer in children, teenagers and young adults (CTYA) presenting to...
GLP-1 therapy boosts visceral fat metabolism, driving weight loss 🔬🧠🌐 www.news-medical.net/news/2024082...#GLP1#VisceralFat#WeightLoss#ObesityResearch#SleepApnea#MetabolicHealth#GutHormones#TherapyInsights#HealthInnovation#Obesity
Researchers discuss the role of enhanced visceral adipose tissue metabolism in mediating weight loss by glucagon-like peptide-1 drugs.
Human gut microbiome: A source of new antibiotic peptides 🔬🧬💊 www.news-medical.net/news/2024082...#Antibiotics#Microbiome#PeptideDiscovery#HealthInnovation#DrugResistance#GutHealth#Biotech#MedicalResearch#Prevotellin2#AntimicrobialResistance
Researchers identified 323 peptide-based antimicrobials from the human microbiome, with 71% showing significant antibacterial activity, and the lead peptide, prevotellin-2, matching the efficacy of po...
The Future of EHRMS in 2024 The future of EHR Management Systems in 2024 looks like this will be even more engaging and transforming. #EHRMS#EHRMSadvancements2024#EHRMSinnovations2024#EmergingEHRMStechnologies2024#TheFutureofEHRMSin2024#HealthInnovation#HealthManagement
The Future of EHRMS in 2024 The future of EHR Management Systems in 2024 looks like this will be even more engaging and transforming. Here are some of the main